Dr. Ram Vromen is the Managing Partner of Evolution Venture Capital Fund. Previously he was a partner at Millennium Materials Technologies Fund, a venture capital fund focused on material sciences, and prior to that, a managing director of First IsraTech Fund, a venture capital fund focused primarily on medical devices. Before embarking on his VC career Vromen was a corporate lawyer focused on the hi-tech and venture capital practice. Ram serves as Chairman of WhiteSmoke Software Ltd. listed on TASE and has been a board member in over 20 private hi-tech companies in the past 15 years, with an investment track record that includes multiple exits such as the listings of Enzymotec and Perion (Incredimail) on Nasdaq, SightLine acquired by Stryker, Cadent acquired by Align Technology Inc. and OreX acquired by Kodak. Ram has a PhD in history from the Ecole Des Hautes Etudes en Sciences Sociales, Paris, France and an LLB in law from Tel Aviv University.